NetworkNewsBreaks – Endonovo Therapeutics Inc. (

NetworkNewsBreaks – Endonovo Therapeutics Inc. (ENDVD) Provides SofPulse(R) Evaluation Units to All NFL Teams

Endonovo Therapeutics (OTCQB: ENDVD), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, today announced the delivery of SofPulse(R) evaluation units to all thirty-two National Football League (“NFL”) teams. “With injuries affecting the NFL more than any other professional sports league, we are pleased to support the health of NFL players by providing SofPulse(R) evaluation units to all NFL teams,” Endonovo Therapeutics CEO Alan Collier said in the news release. “The SofPulse(R) device is clinically proven to reduce post-operative pain, swelling and need for opioids. Endonovo is committed to helping NFL players get back on the field faster when recovering from medical procedures caused by injuries. We are currently expanding our sales and marketing efforts to other leagues and all levels, from high school to professional athletes.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer